✦ LIBER ✦

AN2728 demonstrates significant safety and efficacy in a phase IIa double-blind trial in plaque type psoriasis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AN2728 demonstrates significant efficacy

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficacy and safety of ursodeoxycholic a

✍ Manoela F.B. Braga; Michael G.A. Grace; Jacques Lenis; Frank P. Kennedy; Avery L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Secukinumab efficacy in patients with mo

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy and safety of topical janus kin

📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Efficacy and Safety of Fasudil in Patien

✍ Ralph M. Vicari; Bernard Chaitman; Deborah Keefe; William B. Smith; Steven G. Ch 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB